Linked e-resources
Details
Table of Contents
Chapter 1. Arboviruses on the rise
Chapter 2. Historical perspective of arboviruses in Mozambique and its implication for current and future epidemics
Chapter 3. Reliable serological testing for the diagnosis of emerging infectious diseases
Chapter 4. Flaviviral RNA structures and their role in replication and immunity
Chapter 5. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections
Chapter 6. Structures of Zika virus E & NS1: relations with virus infection and host immune responses
Chapter 7. Plugging the leak – is dengue a case of aseptic shock with NS1 at its center
Chapter 8. Entry & NS1 as drug targets
Chapter 9. The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity
Chapter 10. Crystal structure of Zika virus NS2B-NS3 protease
Chapter 11. The transactions of NS3 and NS5 in Dengue viral RNA replication
Chapter 12. Establishment and application of flavivirus replicons
Chapter 13. Strategies towards protease inhibitors for emerging flaviviruses
Chapter 14. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design
Chapter 15. Nuclear cytoplasmic trafficking of dengue non-structural protein 5 as a target for antivirals
Chapter 16. Animal Models for Dengue and Zika Vaccine Development
Chapter 17 Understandingthe human T cell response to dengue virus
Chapter 18. Regulation and function of NK and T cells during dengue virus infection and vaccination
Chapter 19. Structural insights into the broad-spectrum antiviral target Endoplasmic Reticulum alpha glucosidase II
Chapter 20. Mechanisms of antiviral activity of iminosugars against dengue virus
Chapter 21. Countering Zika Virus: The USAMRIID Response
Chapter 22 Dengue Antiviral Development: A Continuing Journey
Chapter 23 An industry perspective on dengue drug discovery and development
Chapter 24. The use of Wolbachia by the Eliminate Dengue program to interrupt transmission of Aedes Aegypti transmitted viruses
Chapter 25 Seroepidemiological studies of Arboviruses in Africa.
Chapter 2. Historical perspective of arboviruses in Mozambique and its implication for current and future epidemics
Chapter 3. Reliable serological testing for the diagnosis of emerging infectious diseases
Chapter 4. Flaviviral RNA structures and their role in replication and immunity
Chapter 5. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections
Chapter 6. Structures of Zika virus E & NS1: relations with virus infection and host immune responses
Chapter 7. Plugging the leak – is dengue a case of aseptic shock with NS1 at its center
Chapter 8. Entry & NS1 as drug targets
Chapter 9. The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity
Chapter 10. Crystal structure of Zika virus NS2B-NS3 protease
Chapter 11. The transactions of NS3 and NS5 in Dengue viral RNA replication
Chapter 12. Establishment and application of flavivirus replicons
Chapter 13. Strategies towards protease inhibitors for emerging flaviviruses
Chapter 14. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design
Chapter 15. Nuclear cytoplasmic trafficking of dengue non-structural protein 5 as a target for antivirals
Chapter 16. Animal Models for Dengue and Zika Vaccine Development
Chapter 17 Understandingthe human T cell response to dengue virus
Chapter 18. Regulation and function of NK and T cells during dengue virus infection and vaccination
Chapter 19. Structural insights into the broad-spectrum antiviral target Endoplasmic Reticulum alpha glucosidase II
Chapter 20. Mechanisms of antiviral activity of iminosugars against dengue virus
Chapter 21. Countering Zika Virus: The USAMRIID Response
Chapter 22 Dengue Antiviral Development: A Continuing Journey
Chapter 23 An industry perspective on dengue drug discovery and development
Chapter 24. The use of Wolbachia by the Eliminate Dengue program to interrupt transmission of Aedes Aegypti transmitted viruses
Chapter 25 Seroepidemiological studies of Arboviruses in Africa.